Hemostatic compositions and methods of making and using same

US10149926B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10149926-B2
Application numberUS-201514873630-A
CountryUS
Kind codeB2
Filing dateOct 2, 2015
Priority dateAug 31, 2010
Publication dateDec 11, 2018
Grant dateDec 11, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure pertains to hemostatic compositions comprising a plurality of nonwoven fibers disposed in a rapidly soluble solid matrix and methods of making and using the same. The compositions may also comprise one or more therapeutic agents.

First claim

Opening claim text (preview).

What is claimed: 1. A method of sealing a tissue puncture comprising: providing a hemostatic composition comprising: a plurality of nonwoven fibers; a rapidly soluble solid matrix, wherein the fibers are embedded within the rapidly soluble solid matrix such that the space occupied by the fibers is free of voids; and one or more therapeutic agents; inserting the hemostatic composition into a tissue puncture; exposing the hemostatic composition to at least one of a body fluid or saline; liquefying the rapidly soluble solid matrix upon contact with the at least one of a body fluid or saline and releasing the plurality of nonwoven fibers; and allowing the plurality of nonwoven fibers to swell upon contact with the at least one of a body fluid or saline, thereby occluding the tissue puncture. 2. The method of claim 1 , wherein the plurality of nonwoven fibers are greater than about 50 nanometers in diameter and less than about 20 microns in diameter. 3. The method of claim 1 , wherein the plurality of nonwoven fibers comprise a non-cellulosic polysaccharide. 4. The method of claim 1 , wherein the liquefying step releases at least a portion of the one or more therapeutic agents. 5. The method of claim 1 , wherein the rapidly soluble solid matrix comprises a sugar. 6. The method of claim 1 , wherein the rapidly soluble solid matrix consists of a sugar. 7. The method of claim 1 , wherein the rapidly soluble solid matrix comprises water ice. 8. The method of claim 1 , wherein the rapidly soluble solid matrix consists of water ice. 9. The method of claim 1 , wherein the material of the plurality of nonwoven fibers includes crosslinks. 10. The method of claim 1 , wherein the material of the plurality of nonwoven fibers swells upon contact with at least one of a body fluid or saline.

Assignees

Inventors

Classifications

  • Web, sheet or filament bases {; Films; Fibres of the matrix type containing drug (hollow drug-filled fibres A61K9/0092)} · CPC title

  • A61L31/125Primary

    having a macromolecular matrix · CPC title

  • Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect (sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009) · CPC title

  • Anti-inflammatory agents, e.g. NSAIDs · CPC title

  • entirely comprised between the two sides of the opening · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10149926B2 cover?
The disclosure pertains to hemostatic compositions comprising a plurality of nonwoven fibers disposed in a rapidly soluble solid matrix and methods of making and using the same. The compositions may also comprise one or more therapeutic agents.
Who is the assignee on this patent?
Boston Scient Scimed Inc, Boston Scient Scimed Inc
What technology area does this patent fall under?
Primary CPC classification A61L31/125. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).